Clinical Trial of Factor XIII (FXIII) Concentrate
Completed · Not applicable
Conditions studied: Hemophilia, Factor XIII Deficiency
In brief
Congenital deficiency of Factor XIII is a rare but potentially life threatening disorder. It is inherited in an autosomal recessive fashion. Infusion of Factor XIII has proved to be useful for prevention and treatment of bleeding episodes, especially of spontaneous intracranial bleedings. In this study, Fibrogammin P will be given to patients with congenital Factor XIII deficiency and congenital/acquired FXIII deficiency to prevent bleeding and to treat established bleeding episodes. For Factor XIII prophylaxis to prevent hemorrhages, the dosage will depend on the weight of the subject. The frequency of Factor XIII administration will be determined by the factor's circulating half-life. During the first month only, a Factor XIII pharmacokinetic study will be determined over a 4-week period. Safety data will include accrual of information on viral safety, liver function, complete blood counts and adverse events. Historical data concerning spontaneous bleeds will be collected whenever possible two years prior to treatment with Fibrogammin P.
Key facts
- Study ID
- NCT00640289
- Run by
- Children's Hospital of Orange County
- People needed
- 72
- Starts
- 2000-01-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2018-11-07
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients may be of either sex or age. Children and newborn infants are specifically included in this study.
- Patient must have documented congenital Factor XIII deficiency
- Patient or legal guardian must sign informed consent
- Patients who have negative serology for hepatitis B should receive Hepatitis B vaccination.
You may not qualify if…
- Patient has acquired Factor XIII deficiency
Where it is running
- Children's Hospital of Orange Co. — Orange, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.